Nutrien beats first-quarter profit estimates-March 2024-www.financetom.com

Nutrien beats first-quarter profit estimates

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Nutrien beats first-quarter profit estimates

May 8, 2024 3:24 PM

May 8 (Reuters) - Nutrien ( NTR ) beat first-quarter

profit estimates on Wednesday, on strong demand from North

America.

The world's biggest fertilizer producer reported an adjusted

profit of 46 cents per share for the quarter ended March 31,

compared with analysts' average estimate of 39 cents per share,

according to LSEG data.

Previous page： Top Premarket Gainers Next page： James River Group Secures $160 Million Reinsurance Deal with State National Insurance

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Top Premarket Gainers

Jul 10, 2024

07:48 AM EDT, 07/10/2024 (MT Newswires) -- NaaS Technology ( NAAS ) stock was up over 79% in recent Wednesday premarket activity, adding to Tuesday's 68% gain. Ampco-Pittsburgh ( AP ) shares were 49% higher after the company said overnight its Union Electric Steel unit was selected to provide the initial provisioning of rolls for two new rolling mill projects...

James River Group Secures $160 Million Reinsurance Deal with State National Insurance

Jul 10, 2024

07:44 AM EDT, 07/10/2024 (MT Newswires) -- James River Group Holdings ( JRVR ) said late Tuesday that two of its principal subsidiaries entered a reinsurance agreement with State National Insurance to provide $160 million of reinsurance coverage for James River's Excess and Surplus Lines segment for accident years 2010 to 2023, with James River co-participating at 15%. The deal...

Amylyx Pharmaceuticals Acquires Avexitide From Eiger BioPharmaceuticals for $35 Million

Jul 10, 2024

07:46 AM EDT, 07/10/2024 (MT Newswires) -- Amylyx Pharmaceuticals ( AMLX ) said Wednesday that it has acquired avexitide for the potential treatment of hyperinsulinemic hypoglycemia from Eiger BioPharmaceuticals for $35.1 million. Amylyx said it has also assumed certain contractual obligations from Eiger, including a 3% royalty on future sales of avexitide in post-bariatric hypoglycemia, if approved, to certain academic...

Walker & Dunlop Arranges $148 Million Refinancing for New York City Building

Jul 10, 2024

07:44 AM EDT, 07/10/2024 (MT Newswires) -- Walker & Dunlop ( WD ) said Wednesday it has arranged $148 million in loan proceeds for Lam Group and Exact Capital to refinance The Victoria, a 30-story multi-tower project in Harlem, New York City. The loan, which will be used for the building's ongoing operations and future enhancements, was secured from Aareal...